News
-
Alcon acquisition
Tuesday | Mar 19 2019NOVARTIS' eye care division Alcon has announced the acquisition of US-based PowerVision Inc, a privately-held firm focused on creating "fluid-based intraocular lens implants".
-
Dispensary Corner 19 Mar 19
Tuesday | Mar 19 2019WE all know the calcium in dairy products such as cheese is good for bones - but how to ensure that it tastes as good as possible?.
-
NPSA upholds CSO standards
Monday | Mar 18 2019DISTRIBUTING the full range of PBS products to anywhere in Australia and generally within 24 hours, is the key deliverable for the Community Services Agreement (CSO) and needs to be valued, says the National Pharmaceutical Services Association (NPSA).
-
Advert complaints
Monday | Mar 18 2019THE Therapeutic Goods Administration (TGA) has called for health professionals and consumers alike to alert them to advertisements that don't meet the requirements of the Therapeutic Goods Advertising Code.
-
Zoono’s Midas touch
Monday | Mar 18 2019ASX-LISTED New Zealand-based biotech company Zoono Group has signed an agreement with German pharmaceutical and healthcare company Midas Pharma GmbH for sales and distribution in the EU and selected global markets.
-
E-cigarette study
Monday | Mar 18 2019TOBACCO giant Philip Morris International last week released the results of new e-cigarette research at the 58th Annual Society of Toxicology Meeting in the USA.
-
Apple Watch spots AF
Monday | Mar 18 2019DATA presented at the American College of Cardiology (ACC) annual meeting indicate that the Apple Watch was able to spot atrial fibrillation (AF) in certain wearers.
-
CO poisoning device
Monday | Mar 18 2019THE US Food and Drug Administration has approved the marketing of ClearMate, a new device intended to be used to treat patients suffering from carbon monoxide poisoning.
-
Vit D testing still valid
Monday | Mar 18 2019RECENT efforts by health authorities in Australia to restrict testing for levels of vitamin D in patients has been described as a "blunt instrument" in a research article by University of Adelaide authors Dr David Gonzalez-Chica and Professor Nigel Stocks.